β¨ Medicines Act Notices
24 FEBRUARY NEW ZEALAND GAZETTE 909
Area: 6.0829 hectares, more or less.
Also Section 6, Block IX, Oroua Survey District.
Area: 1017 square metres, more or less.
As witness the hand of Her Excellency the Governor-General, signed this 25th day of February 1994.
B. ENGLISH, Parliamentary Under Secretary.
gol1295
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 24(5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Cyclosporin A 100 mg/ml in 50 ml | Oral solution | Sandoz Pharma Limited, Basle, Switzerland | Sandimmun |
| Cyclosporin A 25 mg, 100 mg | Capsules | Sandoz Pharma Limited, Basle, Switzerland | Sandimmun |
| Enoxaparin 20 mg/0.2 ml, 40 mg/0.4 ml, | Injection | Rhone-Poulenc Sante Propharm, Maisons-Alfort, France | Clexane |
| 60 mg/0.6 ml, 80 mg/0.8 ml, 100 mg/1 ml | |||
| Alprostadil 20 mcg/ml | Powder for reconstitution for injection | Upjohn SA, Puurs, Belgium | Caverject |
| Ciclopirox 8% | Nail lacquer | Hoechst AG, Frankfurt (Main), Germany | Batrafen |
| Budesonide 0.025% w/v | Lotion | Royal Gist-Brocades Pharma BV, Meppel, The Netherlands | Preferid |
| Somatropin (human growth hormone rDNA origin) 4IU/ml, 16IU/ml | Lyophilized powder for reconstitution for injection | Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France SA, Fegersheim, France | Humatrope for injection |
| Diclofenac 46.5 mg (equivalent to 50 mg diclofenac sodium) | Tablet | Ciba-Geigy Limited, Stein, Switzerland and Ciba-Geigy Pharmaceuticals Division, Horsham, West Sussex, England | Voltarol D |
| Olsalazine sodium 500 mg | Tablet | Kabi Pharmacia AB, Uppsala, Sweden | Dipentum |
| Hydrocortisone acetate 1% w/w | Topical cream | The Boots Company PLC., Nottingham, England | Hc45 Hydrocortisone Cream |
| Inactivated hepatitis A virus 1440 ELISA units/1 ml | Solution for injection | SmithKline Beecham Biologicals, Rixensart, Belgium | Havrix 1440 Vaccine |
| Atenolol 50 mg/12.5 mg chlorthalidone, atenolol 100 mg/25 mg chlorthalidone | Tablets | Gerard Laboratories, Dublin, Ireland | Lo-Ten C |
- This replaces the entry in the notice published in the New Zealand Gazette, 13 August 1992, 127, notice number 7425, page 2768
Dated this 17th day of February 1994.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
gol1433
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Mesalazine 400 mg | Tablet | SmithKline Beecham Pharma GmbH, Gronau/Leine, Germany | Asacol |
| Famotidine 20 mg, 40 mg | Wafer | R P Scherer, Blagrove, Swindon, Wiltshire, England | Pepcidine RPD |
| Cilazapril 5 mg, hydrochlorothiazide 12.5 mg | Tablet | F Hoffmann-La Roche & Co, Aktiengesellschaft, Basle, Switzerland | Inhibace Plus |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1994, No 16
NZLII —
NZ Gazette 1994, No 16
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare17 February 1994
Medicines, Distribution, Consent, Schedule, Medicines Act 1981
- C. Lovelace, Director-General of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Schedule, Medicines Act 1981